DexCom, Inc. (DXCM)

71.69 +0.96 (+1.36%) USD  |  NASDAQ  |  Jan 21, 11:31
More

DexCom EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for DXCM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Abbott Laboratories Upgrade
BioLife Solutions, Inc. Upgrade
Boston Scientific Corp. Upgrade
Krystal Biotech, Inc. Upgrade
Tandem Diabetes Care, Inc. Upgrade